“Hispanics & Personalized Medicine:
Bridging Gaps between Genes, Culture, and Ethnicity”
Jose Calderon, MD
Anita Goel, MD, PhD
James Gillespie, JD, PhD
Emerging research demonstrates that genetic variations affecting Hispanic Americans may require dosage adjustments to achieve desired physical results and optimal healthcare outcomes. This NHLSS research study examines the significant collection of scientific research on substantial disparities in pharmaceutical therapy for Hispanic Americans. The vision is to create the world’s preeminent research report on the relationships between Hispanic Americans, personalize medicine, and healthcare outcomes.
Biographies of the Authors
Dr. José Luis Calderon is an Assistant Professor, Department of Ophthalmology at the Charles R. Drew University of Medicine andHealth Science, Los Angeles. He is director of the NIH funded Drew University Center of Cross-Cultural Epidemiologic Studies (DUCES), the UCLA/DrewMeasurement Core, and the RCMI Translational Research Network, Minority Involvement in Clinical Research Opportunities (MICRO) Core. He is currentlyPresident of the Association for the Behavioral Sciences and Medical Education(ABSAME), and Associate Editor for Health Communications for the Latino MedJournal. He is a board member of the Association for the Behavioral Sciences andMedical Education, the Live a Difference Foundation, Washington, DC and theHispano American Biomedical Society, NY, and the CF Faura Alzheimer’sFoundation, Carlsbad, CA. Dr. Calderón was conferred with a Bachelor of Science with honors from the University at Albany, NY in 1977 and an MD from HarvardMedical School in 1982. After training in Family Medicine at the State University of New York’s Brooklyn Health Sciences Center he practiced familymedicine in the Bronx and Brooklyn in underserved Latino and African-Americancommunities until re-training in Neurology at New York University-Bellevue Hospital Medical Center in 1990. He has completed graduate fellowships inEpidemiology at the Bloomberg School of Public Health, Johns Hopkins University and in Health Services Research at the Health Services Research Institute ofthe American Association of Medical Colleges, Washington, D.C.
Dr. Anita Goel is a Harvard University, Stanford University, and Massachusetts Institute of Technology educated doctor, physicist, and expert on nanotechnology and biotechnology. She has trained under the direct supervision of two Nobel Laureates. She obtained her PhD from the Physics Department at Harvard University, under the mentorship of Nobel Prize winner Dudley R. Herschbach, with a thesis entitled Single Molecule Dynamics of Motor Enzymes Along DNA. Her physics honors thesis mentor at Stanford University was Nobel Laureate Steven Chu. She also holds an MD from the Harvard-MIT Joint Division of Health Sciences and Technology (HST). Goel was named one of the world’s “top 35 science and technologyinnovators under the age of 35” by MIT’s Technology Review Magazine. Sheis the Founder, Chairman, and CEO of Nanobiosym, Inc. Her work at Nanobiosym has been recognized by a number of prestigious funding awards from the United States Department ofDefense and DARPA, DTRA, and US Department of Energy. The recipient of numerous honors and an esteemed speaker at major international conferences, Goel has quickly emerged as a leading researcher in the field of nanobiophysics and nanobiotechnology. Goel is also a Fellow of the World Technology Network, a Fellow-at-Large of the Santa Fe Institute and Adjunct Professor at the Beyond Institute for Fundamental Concepts in Physics, and anAssociate of the Harvard Physics Department. While at Stanford University,Goel envisioned building a hi-tech bridge between developed and developing world countries. Inspired by this vision, Goel founded and chaired SETU (Sanskrit for “bridge”), an international conference and think tank composed ofworld leaders from academic, business, political, and humanitarian sectorsdedicated to bridging these worlds.
Dr. James J. Gillespie is President & Co-Founder of the Center for Healthcare Innovation, a research center and thought-leadership institution focusing on the global life sciences industry. Dr. Gillespie is a scholar, executive, and entrepreneur, with an expertise focusing on the strategy, operations, and technology of the biotechnology, medical device, and pharmaceutical sectors. He is Managing Director for Life Sciences at Semplar, a boutique management consulting firm. Dr. Gillespie is President & Co-Founder of the National Hispanic Life Science Society, the leading professional organization for Hispanic/Latino-Americans in the life sciences industry. He serves on the Board of Directors for i.c.stars (Chair, Program Committee), the Board of Directors of the America-Israel Chamber of Commerce Chicago (First Vice President; Chair, Membership Committee). Dr. Gillespie chairs the annual symposium “Globalization of Innovation: China, India, and US Pharmaceutical Markets” hosted by Microsoft Corporation and co-sponsored by Pharmaceutical Executive Magazine. He also chairs the annual conference “U.S.-Israel Healthcare Innovation: The Future of Imaging & Radiology”. Dr. Gillespie’s research has appeared in Academy of Management Review, European Journal of Social Psychology, Harvard Business Review, and Strategic Management Journal. His education includes Northwestern University Kellogg School of Management, M.A., Ph.D.; Harvard University School of Law, J.D.; Princeton University Woodrow Wilson School of Public Policy, M.P.A.; Massachusetts Institute of Technology, B.S.; and Carnegie Mellon University.